SE421614B - Forfarande for framstellning av vissa terapeutiskt aktiva 9-oxo-1-prostanoler - Google Patents

Forfarande for framstellning av vissa terapeutiskt aktiva 9-oxo-1-prostanoler

Info

Publication number
SE421614B
SE421614B SE7500798A SE7500798A SE421614B SE 421614 B SE421614 B SE 421614B SE 7500798 A SE7500798 A SE 7500798A SE 7500798 A SE7500798 A SE 7500798A SE 421614 B SE421614 B SE 421614B
Authority
SE
Sweden
Prior art keywords
prostanols
oxo
procedure
therapeutically active
preparing certain
Prior art date
Application number
SE7500798A
Other languages
English (en)
Swedish (sv)
Other versions
SE7500798L (US06521211-20030218-C00004.png
Inventor
M P L Caton
E C J Coffee
G L Watkins
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of SE7500798L publication Critical patent/SE7500798L/xx
Publication of SE421614B publication Critical patent/SE421614B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7500798A 1974-01-26 1975-01-24 Forfarande for framstellning av vissa terapeutiskt aktiva 9-oxo-1-prostanoler SE421614B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB373074A GB1468830A (en) 1974-01-26 1974-01-26 Cyclopentane derivatives

Publications (2)

Publication Number Publication Date
SE7500798L SE7500798L (US06521211-20030218-C00004.png) 1975-07-28
SE421614B true SE421614B (sv) 1982-01-18

Family

ID=9763869

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7500798A SE421614B (sv) 1974-01-26 1975-01-24 Forfarande for framstellning av vissa terapeutiskt aktiva 9-oxo-1-prostanoler

Country Status (20)

Country Link
US (1) US4088695A (US06521211-20030218-C00004.png)
JP (1) JPS5817747B2 (US06521211-20030218-C00004.png)
AU (1) AU498990B2 (US06521211-20030218-C00004.png)
BE (1) BE824773A (US06521211-20030218-C00004.png)
CA (1) CA1055488A (US06521211-20030218-C00004.png)
CH (1) CH609664A5 (US06521211-20030218-C00004.png)
CS (1) CS189682B2 (US06521211-20030218-C00004.png)
CY (1) CY1058A (US06521211-20030218-C00004.png)
DE (1) DE2502919C2 (US06521211-20030218-C00004.png)
DK (1) DK23075A (US06521211-20030218-C00004.png)
FI (1) FI750196A (US06521211-20030218-C00004.png)
FR (1) FR2258845B1 (US06521211-20030218-C00004.png)
GB (1) GB1468830A (US06521211-20030218-C00004.png)
HK (1) HK48380A (US06521211-20030218-C00004.png)
HU (1) HU172827B (US06521211-20030218-C00004.png)
IE (1) IE40571B1 (US06521211-20030218-C00004.png)
LU (1) LU71716A1 (US06521211-20030218-C00004.png)
NL (1) NL183399B (US06521211-20030218-C00004.png)
SE (1) SE421614B (US06521211-20030218-C00004.png)
ZA (1) ZA75518B (US06521211-20030218-C00004.png)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7605381A (nl) * 1975-05-26 1976-11-30 Schering Ag Werkwijze voor het bereiden van prostaanderi- vaten en werkwijze voor het bereiden van een geneesmiddel met prostaglandinewerking.
DE2715838A1 (de) * 1977-04-05 1978-10-19 Schering Ag Neue prostanderivate und verfahren zu ihrer herstellung
GB1581886A (en) * 1977-05-26 1980-12-31 May & Baker Ltd Prostanol derivatives
JPH085794B2 (ja) * 1989-07-27 1996-01-24 株式会社上野製薬応用研究所 高脂質血症処置・血中脂質成分低下剤
JPH0769897A (ja) * 1993-09-01 1995-03-14 Green Cross Corp:The 血中トリグリセリド低下作用剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1451798A (en) * 1973-08-02 1976-10-06 Ici Ltd Prostanoic acid derivatives

Also Published As

Publication number Publication date
SE7500798L (US06521211-20030218-C00004.png) 1975-07-28
CS189682B2 (en) 1979-04-30
NL183399B (nl) 1988-05-16
FI750196A (US06521211-20030218-C00004.png) 1975-07-27
US4088695A (en) 1978-05-09
BE824773A (fr) 1975-07-24
JPS50106941A (US06521211-20030218-C00004.png) 1975-08-22
CY1058A (en) 1980-08-01
CA1055488A (en) 1979-05-29
JPS5817747B2 (ja) 1983-04-09
FR2258845A1 (US06521211-20030218-C00004.png) 1975-08-22
AU498990B2 (en) 1979-03-29
ZA75518B (en) 1976-01-28
IE40571L (en) 1975-07-26
HU172827B (hu) 1978-12-28
LU71716A1 (US06521211-20030218-C00004.png) 1975-12-09
FR2258845B1 (US06521211-20030218-C00004.png) 1980-01-25
GB1468830A (en) 1977-03-30
DK23075A (US06521211-20030218-C00004.png) 1975-09-15
DE2502919C2 (de) 1985-06-27
CH609664A5 (US06521211-20030218-C00004.png) 1979-03-15
DE2502919A1 (de) 1975-07-31
HK48380A (en) 1980-09-05
NL7500868A (nl) 1975-07-29
IE40571B1 (en) 1979-07-04
AU7762175A (en) 1976-07-29

Similar Documents

Publication Publication Date Title
SE423633B (sv) Forfarande for framstellning av 4-demetoxi-daunomycin
SE427752B (sv) Forfarande for framstellning n-fosfonometylglycin
SE428562B (sv) Forfarande for framstellning av purinderivat
NO149106C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzcykloamider
DK268975A (da) Farmakologisk aktive forbindelser
SE7513085L (sv) Forfarande for framstellning av etrar
IT1042173B (it) Procedimento per preparare butandioli
SE431211B (sv) Forfarande for framstellning av n-acylamino-alfa-arylacetamido-cefalosporiner
SE412066B (sv) Forfarande for framstellning av famakologiskt verksamma tienodiazinderivat
SE7506160L (sv) Forfarande for framstellning av n-cykloalkylmetyldekahydroisokinoline
SE421612B (sv) Forfarande for framstellning av alfa-6-deoxi-5-hydroxitetracyklin
NO141894C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyridobenzodiazepinoner
SE418292B (sv) Forfarande for framstellning av 5-aryl-2-furamidiner
SE428686B (sv) Forfarande for framstellning av antiinflammatoriskt aktiva imidazoler
SE400960B (sv) Forfarande for framstellning av alhŸ3 (poŸ4)Ÿ2 3hŸ2o
SE411453B (sv) Forfarande for framstellning av 3-fluorcefalosporiner
SE414926B (sv) Forfarande for framstellning av 1-alkyl-2-(fenoximetyl)-5-nitroimidazoler
SE417509B (sv) Forfarande for framstellning av anthelmintiskt aktiva 2-karbalkoxiamino-5 (6)-fenyl-sulfonyloxi-bensimidazoler
NO145383C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte indoler.
SE421614B (sv) Forfarande for framstellning av vissa terapeutiskt aktiva 9-oxo-1-prostanoler
NO146142C (no) Fremgangsmaate for behandling av trefils
SE414029B (sv) Forfarande for framstellning av terapeutiskt aktiva fentiazinderivat
SE404364B (sv) Forfarande for framstellning av vissa angivna 5-sulfonylfenyl-tetrazolderivat
SE7511801L (sv) Forfarande for framstellning av ympsampolymerisat
NO141608C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkanolaminderivater

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7500798-9

Effective date: 19910805

Format of ref document f/p: F